Literature DB >> 26643569

Kidney cancer: Novel drug for renal cell carcinoma.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26643569     DOI: 10.1038/nrurol.2015.296

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.

Authors:  Fernando Doñate; Arthur Raitano; Kendall Morrison; Zili An; Linnette Capo; Hector Aviña; Sher Karki; Karen Morrison; Peng Yang; Jimmy Ou; Ryuichi Moriya; Yuriy Shostak; Faisal Malik; Rossana Nadell; Wendy Liu; Daulet Satpayev; John Atkinson; Ingrid B J Joseph; Daniel S Pereira; Pia M Challita-Eid; David R Stover
Journal:  Clin Cancer Res       Date:  2015-11-20       Impact factor: 12.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.